发明授权
EP2099485B1 ALPHAVIRUS AND ALPHAVIRUS REPLICON PARTICLE FORMULATIONS AND METHODS
有权
ALPHAVIRUS和ALPHAVIRUS REPLICON颗粒制剂和方法
- 专利标题: ALPHAVIRUS AND ALPHAVIRUS REPLICON PARTICLE FORMULATIONS AND METHODS
- 专利标题(中): ALPHAVIRUS和ALPHAVIRUS REPLICON颗粒制剂和方法
-
申请号: EP07844849.5申请日: 2007-11-02
-
公开(公告)号: EP2099485B1公开(公告)日: 2018-03-21
- 发明人: DEPAZ, Roberto A. , TALARICO, Todd L.
- 申请人: AlphaVax, Inc.
- 申请人地址: 2 Triangle Drive Research Triangle Park, NC 27709-0307 US
- 专利权人: AlphaVax, Inc.
- 当前专利权人: AlphaVax, Inc.
- 当前专利权人地址: 2 Triangle Drive Research Triangle Park, NC 27709-0307 US
- 代理机构: FRKelly
- 优先权: US864366P 20061103
- 国际公布: WO2008058035 20080515
- 主分类号: A61K39/12
- IPC分类号: A61K39/12 ; A61K9/19 ; C12N15/86 ; C12N7/00 ; A61K39/00
摘要:
Disclosed are methods for preparing dried (preferably lyophilized) preparations comprising a population of alphaviruses or alphavirus replicon particles, a sugar or polyol, a surfactant and a salt and preparations made by said methods, both in the dried form but also as liquids prior to drying or after reconstituting dried preparations. These preparations may further comprise a plasticizer and/or a bulking agent. These preparations are readily reconstituted, with little or no loss in infectivity of the viruses or replicon particles.
公开/授权文献
信息查询